DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Zelniker TA, Wiviott SD, Raz I. et al
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.
Lancet 2019;
393: 31-39
DOI: 10.1016/S0140-6736(18)32590-X.
We do not assume any responsibility for the contents of the web pages of other providers.